birdflustocks.com
Home
Facts
Idea
Stocks
Brokers
July 2, 2024
birdflustocks.com
»
2024 July 02
July 2, 2024
Moderna: BARDA funding for phase 3 trial of H5N1 mRNA vaccine
By
admin
|
2
Jul, 24
|
Moderna, Inc. (NASDAQ:MRNA) today announced a project award of $176
